106 / 1851
Program
name
Lead
organizatio
n
Design Histology Indication
# Expected
to accrue
Primary
outcome
measure(s)
Clinicaltrial
s.gov
identifier
SPECTA EORTC NR
Advanced
colorectal
cancer
Metastatic 2,600
TMA
(screening)
NCT017239
69
Thoracic
tumors
Any stage 3,500
TMA
(screening)
NCT022141
34
Brain
neoplasms
Any stage 300
TMA
(screening)
NCT023076
04
VE-BASKET
Hoffmann-
La Roche
NR
BRAF
V600E
-
mutated
advanced
solid
tumors
Metastatic 160
ORR
NCT015249
78
Basket trials matching patients to therapies
based on molecular profiles